Catalysis research at HZB gets new facility
The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. © D. Amkreutz/HZB
Each block of the chemical reactors is roughly 3 to 4 meters wide and a bit under 2 meters high. The facility consists of two blocks and weighs 3 tons in total. © R. Schlatmann/HZB
As part of the CatLab project, HZB has acquired a unique facility for measuring the catalytic performance of thin-film catalysts. Built by ILS in Adlershof, it has now been delivered. The facility consists of a total of eight chemical reactors in which catalytic systems can be tested. At over €2.5 million, this is the largest single investment in the CatLab project.
‘The reactors enable thin-film and powder samples to be examined continuously or in batches under adjustable conditions, from room temperature to 780 °C, at pressures up to 50 bar and different flow rates and residence times. This allows us to investigate a wide range of chemical reactions that are important for the energy transition,’ says project manager Dr. Ing. Albert Gili from HZB.
Examples of such reactions include the conversion of carbon dioxide to methanol, the dry reforming of methane, and the Fischer-Tropsch synthesis, which can be used to produce synthetic fuels. The facility enables the screening of catalyst candidates, kinetic investigations, and studies on the long-term stability of catalysts. The latter is a decisive factor for the industrial implementation of any catalytic reaction. ‘The facility will be a cornerstone for the further development of thin-film catalyst production, not only for CatLab, but also for our in-house research and other important projects such as CARE-O-SENE, Greenquest and several new ones in the pipeline,’ says Prof. Dr. Rutger Schlatmann, CatLab overall project lead at HZB.
- Protein crystallography at BESSY II: faster, better and more and more automaticMany diseases are linked to malfunctions of proteins in the organism. The three-dimensional architecture of these molecules is often highly complex, but it can provide valuable insights into biological processes and the development of drugs. X-ray diffraction at the MX beamlines of BESSY II can be used to decipher the 3D structure of proteins. To date, more than 5000 structures have been solved at the three MX beamlines. Here, we present a review and an outlook with Manfred Weiss, head of the research group for macromolecular crystallography.
- Humboldt-Fellow at HZB-Institute for Solar Fuels: Alexander R. UhlAlexander R. Uhl, UBC Okanagan School of Engineering in Kelowna, Canada, aims to develop with Roel van de Krol from the HZB Institute for Solar Fuels an efficient and inexpensive photoelectrolyser for producing hydrogen using sunlight. His stay is being funded by the Alexander von Humboldt Foundation.
- 5000th protein structure at BESSY II: Starting point for a COVID drugMany proteins have a complex architecture that enables biological functions. Molecules can bind to specific sites on a protein and alter its function. A team at HZB has now investigated the Nsp1 protein, which plays a role in infection with the SARS-CoV-2 virus. They analysed protein crystals, previously mixed with molecules from a fragment library, and discovered a total of 21 candidates as starting points for drug development. At the same time, they also decoded the 5000th structure at BESSY II.